Phase II 'Proof of Concept' Trial Evaluating Anti Cancer Stem Cell Activity of Pre-operative Bevacizumab in Combination With Chemotherapy in Breast Cancer.

Trial Profile

Phase II 'Proof of Concept' Trial Evaluating Anti Cancer Stem Cell Activity of Pre-operative Bevacizumab in Combination With Chemotherapy in Breast Cancer.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 05 May 2017

At a glance

  • Drugs Bevacizumab (Primary) ; Cyclophosphamide; Docetaxel; Epirubicin; Fluorouracil; Trastuzumab
  • Indications Breast cancer
  • Focus Therapeutic Use
  • Acronyms AVASTEM
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 19 Mar 2013 Planned end date changed from 1 May 2018 to 1 May 2017 as reported by ClinicalTrials.gov.
    • 19 Mar 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top